Some 31,000 units of preservative-free methotrexate, equivalent to a month's supply of the drug for the entire nation, are currently on their way to hospitals around the country, said Michael Ball, CEO of the drug manufacturer Hospira, in a Food and Drug Administration (FDA) press conference on Tuesday. "Next week," said Ball, "we'll release 34,000 vials, another month's worth.
We get many journals here at the CURE office as you can imagine.
Cancer and Careers is hosting a conference on June 22 in New York City for patients and survivors.
US FDA acts to stem shortages of two cancer drugs
Men opting for costly new prostate cancer treatment
Astra takes brand cancer drug straight to patients
Experimental low-weight heparin cuts clot risk in cancer chemotherapy
Drug shortage bill may ride U.S. highway legislation